These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29424303)

  • 1. Antiplatelet for Coronary Artery Disease in Specific Condition "No Size Fits All".
    Setiadi BM; Hartono B; Prakoso AB; Lubis AC; Munandar RM; Munawar M
    Curr Pharm Des; 2018; 24(4):478-495. PubMed ID: 29424303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual antiplatelet therapy for treatment and secondary prevention of coronary artery disease: indications, modalities and duration].
    Degrauwe S; Iglesias JF
    Rev Med Suisse; 2016 May; 12(520):1022-6, 1028-34. PubMed ID: 27424342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.
    Packard KA; Campbell JA; Knezevich JT; Davis EM
    Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.
    Pareek M; Bhatt DL; Ten Berg JM; Kristensen SD; Grove EL
    Expert Opin Pharmacother; 2017 Jun; 18(9):875-883. PubMed ID: 28489475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome.
    Olivier CB; Turakhia MP; Mahaffey KW
    Expert Opin Drug Saf; 2018 Mar; 17(3):251-258. PubMed ID: 29363352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease.
    Farag M; Gorog DA
    Curr Pharm Des; 2017; 23(9):1315-1327. PubMed ID: 28137225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.
    Moseley AD; Collado FM; Volgman AS; Schaer GL; Snell RJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):45. PubMed ID: 27260146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Qin T; Chen MH
    BMC Cardiovasc Disord; 2015 Oct; 15():118. PubMed ID: 26450578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].
    Gallet R; Teiger E
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in antiplatelet agents used in cardiovascular diseases.
    Cheng JW
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of novel antiplatelet agents in acute coronary syndromes.
    Luna M; Holper EM
    Curr Atheroscler Rep; 2015 Mar; 17(3):483. PubMed ID: 25663559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet Treatment for Catheter-Based Interventions in High-Risk Patients: Current Guidelines and Expert Opinion.
    Rath D; Gawaz M
    Hamostaseologie; 2018 Nov; 38(4):229-235. PubMed ID: 30089329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Angiolillo DJ
    Curr Pharm Des; 2012; 18(33):5273-93. PubMed ID: 22724415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
    Liu L; Huang J; Zhang X; Tang X
    PLoS One; 2018; 13(6):e0199232. PubMed ID: 29920547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.